Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Exosome Diagnostics Names O'Neill as CMO

Premium

Exosome Diagnostics said this week that it has appointed Vincent O'Neill as chief medical officer.

O'Neill most recently served as global head of personalized medicine and companion diagnostics at Sanofi. Prior to this, he managed the clinical development programs of several oncology therapeutic candidates at Genetech and GlaxoSmithKline. He holds a BS in pathology and MBChB and MD from the University of Glasgow.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.